Canadian male military personnel with PTSD , who despite standard treatment continued to experience trauma-related nightmares , received double-blind treatment with 0.5 mg NAB or placebo ( PBO ) , and then titrated to the effective dose ( nightmare suppression ) or reaching a maximum of 3.0 mg .